Biochemical characteristics of variant transthyretins causing hereditary leptomeningeal amyloidosis

Amyloid

Volumn 12, Issue 4, 2005, Pages 216-225

  Mitsuhashi, Shigeaki ^a   Yazaki, Masahide ^a   Tokuda, Takahiko ^a   Sekijima, Yoshiki ^a   Washimi, Yukihiko ^b   Shimizu, Yuko ^c   Ando, Yukio ^d   Benson, Merrill D ^e   Ikeda, Shu Ichi ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b CHUBU NATIONAL HOSPITAL   (Japan)

^c TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^d KUMAMOTO UNIVERSITY   (Japan)

^e INDIANA UNIVERSITY   (United States)

Author keywords

Hereditary leptomeningeal TTR amyloidosis; Instability of TTR tetramer; Mass spectrometry; Transthyretin; TTR tetramerization

Indexed keywords

ISOPROTEIN; PREALBUMIN;

ADULT; AGED; AMYLOIDOSIS; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CHEMICAL ANALYSIS; CHOROID PLEXUS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOPRECIPITATION; LEPTOMENINX; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NEUROPATHOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN SECRETION; PROTEIN VARIANT; SUBARACHNOID SPACE;

ADULT; AGED; AMINO ACID SUBSTITUTION; AMYLOIDOSIS, FAMILIAL; CHOROID PLEXUS; FEMALE; HUMANS; MALE; MIDDLE AGED; POINT MUTATION; PREALBUMIN; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 30744440378     PISSN: 13506129     EISSN: 17442818     Source Type: Journal    
DOI: 10.1080/13506120500352404     Document Type: Article

References (37)

1. Tawara S, Nakazato M, Kangawa K, Matsuo H, Araki S. Identification of amyloid prealbumin variant in familial amyloidotic polyneuropathy (Japanese type). Biochem Biophys Res Commun 1983;116:880-888.
2. Kelly JW, Colon W, Lai Z, Lashuel HA, McCulloch J, McCutchen SL, Miroy GJ, Peterson SA. Transthyretin quaternary and tertiary structural changes facilitate misassembly into amyloid. Adv Protein Chem 1997;50:161-181.
3. Connors LH, Lim A, Prokaeva T, Roskens VA, Costello CE. Tabulation of human transthyretin (TTR) variants, 2003. Amyloid 2003;10:160-184.
4. Ikeda S, Nakazato M, Ando Y, Sobue G. Familial transthyretin-type amyloid polyneuropathy in Japan: clinical and genetic heterogeneity. Neurology 2002;58:1001-1007.
5. Ikeda S, Takei Y, Tokuda T, Nakazato M, Ando Y. Clinical and pathological findings of non-Val30Met TTR type familial amyloid polyneuropathy in Japan. Amyloid 2003;10(Suppl):139-147.
6. Dwulet FE, Benson MD. Characterization of a transthyretin (prealbumin) variant associated with familial amyloidotic polyneuropathy type II (Indiana/Swiss). J Clin Invest 1986;78:880-886.
7. Ueno S, Fujimura H, Yorifuji S, Nakamura Y, Takahashi M, Tarui S, Yanagihara T. Familial amyloid polyneuropathy associated with the transthyretin Cys114 gene in a Japanese kindred. Brain 1992;115:1275-1289.
8. Garzuly F, Wisniewski T, Brittig F, Budka H. Familial meningocerebrovascular amyloidosis, Hungarian type, with mutant transthyretin (TTR Asp18Gly). Neurology 1996;47:1562-1567.
9. Herrick MK, DeBruyne K, Horoupian DS, Skare J, Vanefsky MA, Ong T. Massive leptomeningeal amyloidosis associated with a Val30Met transthyretin gene. Neurology 1996;47:988-992.
10. Petersen RB, Goren H, Cohen M, Richardson SL, Tresser N, Lynn A, Gali M, Estes M, Gambetti P. Transthyretin amyloidosis: A new mutation associated with dementia. Ann Neurol 1997;41:307-313.
11. Brett M, Persey MR, Reilly MM, Revesz T, Booth DR, Booth SE, Hawkins PN, Pepys MB, Morgan-Hughes JA. Transthyretin Leu12Pro is associated with systemic, neuropathic and leptomeningeal amyloidosis. Brain 1999;122:183-190.
12. Mascalchi M, Salvi F, Pirini MG, D'Errico A, Ferlini A, Lolli F, Plasmati R, Tessa C, Villari N, Tassinari CA. Transthyretin amyloidosis and superficial siderosis of the CNS. Neurology 1999;53:1498-1503.
13. Uemichi T, Uitti RJ, Koeppen AH, Donat JR, Benson MD. Oculoleptomeningeal amyloidosis associated with a new transthyretin variant Ser64. Arch Neurol 1999;56:1152-1155.
14. Ellie E, Camou F, Vital A, Rummens C, Grateau G, Delpech M, Valleix S. Recurrent subarachnoid hemorrhage associated with a new transthyretin variant (Gly53Glu). Neurology 2001;57:135-137.
15. Sekijima Y, Hammarström P, Matsumura M, Shimizu Y, Iwata M, Tokuda T, Ikeda S, Kelly JW. Energetic characteristics of the new transthyretin variant A25T may explain its atypical central nervous system pathology. Lab Invest 2003;83:409-417.
16. Blevins G, Macaulay R, Harder S, Fladeland D, Yamashita T, Yazaki M, Hamidi Asl K, Benson MD, Donat JR. Oculoleptomeningeal amyloidosis in a large kindred with a new transthyretin variant Tyr69His. Neurology 2003;60:1625-1630.
17. Jin K, Sato S, Takahashi T, Nakazaki H, Date Y, Nakazato M, Tominaga T, Itoyama Y, Ikeda S. Familial leptomeningeal amyloidosis with a transthyretin variant Asp18Gly representing repeated subarachnoid hemorrhages with superficial siderosis. J Neurol Neurosurg Psychiatry 2004;75:1463-1466.
18. Hammarström P, Sekijima Y, White JT, Wiseman RL, Lim A, Costello CE, Altland K, Garzuly F, Budka H, Kelly JW. D18G transthyretin is monomeric, aggregation prone, and not detectable in plasma and cerebrospinal fluid: A prescription for central nervous system amyloidosis? Biochemistry 2003;42:6656-6663.
19. Tachibana N, Tokuda T, Yoshida K, Taketomi T, Nakazato M, Li YF, Masuda Y, Ikeda S. Usefulness of MALDI/TOF mass spectrometry immunoprecipitated serum variant transthyretin in the diagnosis of familial amyloid polyneuropathy. Amyloid 1999;6:282-288.
20. Yazaki M, Yamashita T, Kincaid JC, Scott JR, Auger RG, Dyck PJ, Benson MD. Rapidly progressive amyloid polyneuropathy associated with a novel variant transthyretin serine 25. Muscle Nerve 2002;25:244-250.
21. Murakami T, Atsumi T, Maeda S, Tanase S, Ishikawa K, Mita S, Kumamoto T, Araki S, Ando M. A novel transthyretin mutation at position 30 (Leu for Val) associated with familial amyloidotic polyneuropathy. Biochem Biophys Res Commun 1992;187:397-403.
22. Reilly MM, Adams D, Booth DR, Davis MB, Said G, Laubriat-Bianchin M, Pepys MB, Thomas PK, Harding AE. Transthyretin gene analysis in European patients with suspected familial amyloid polyneuropathy. Brain 1995;118:849-856.
23. Yazaki M, Takei Y, Katoh M, Ikeda S. Postmortem findings in two familial amyloidosis patients with transthyretin variant Asp38A1a. Amyloid 2000;7:270-277.
24. Nishi H, Kimura A, Harada H, Hayashi Y, Nakamura M, Sasazuki T. Novel variant transthyretin gene (Ser50 to Ile) in familial cardiac amyloidosis. Biochem Biophys Res Commun 1992;187:460-466.
25. Ueno S, Uemichi T, Takahashi N, Soga F, Yorifuji S, Tarui S. Two novel variants of transthyretin identified in Japanese cases with familial amyloidotic polyneuropathy: Transthyretin (Glu42 to Gly) and transthyretin (Ser50 to Arg). Biochem Biophys Res Commun 1990;169:1117-1121.
26. Wallace MR, Dwulet FE, Conneally PM, Benson MD. Biochemical and molecular genetic characterization of a new variant prealbumin associated with hereditary amyloidosis. J Clin Invest 1986;78:6-12.
27. Takei Y, Hattori T, Yazaki M, Tokuda T, Urasawa N, Kanai S, Ikeda S. Transthyretin Tyr69-to-Ile mutation (double-nucleotide substitution in codon 69) in a Japanese familial amyloidosis patient with cardiomyopathy and carpal tunnel syndrome. Amyloid 2003;10:25-28.
28. Murakami T, Tachibana S, Endo Y, Kawai R, Hara M, Tanase S, Ando M. Familial carpal tunnel syndrome due to amyloidogenic transthyretin His 114 variant. Neurology 1994;44:315-318.
29. Sekijima Y, Tokuda T, Kametani F, Tanaka K, Maruyama K, Ikeda S. Serum transthyretin monomer in patients with familial amyloid polyneuropathy. Amyloid 2001;8:257-262.
30. Tojo K, Tokuda T, Yazaki M, Oide T, Nakamura A, Mitsuhashi S, Kaneko K, Maruyama K, Kametani F, Higuchi K, Ikeda S. Paraneoplastic sensorimotor neuropathy and encephalopathy associated with anti-alpha-enolase antibody in a case of gastric adenocarcinoma. Eur Neurol 2004;51:231-233.
31. Nakazato M, Kurihara T, Kangawa K, Matsuo H. Diagnostic radioimmunoassay for familial amyloidotic polyneuropathy. Lancet 1984;2:1274-1275.
32. Haagsma EB, Post JG, De Jager AEJ, Nikkels PGJ, Hamel BCJ, Hazenberg BPC. A Duch kindred with familial amyloidotic polyneuropathy associated with the transthyretin Cys114 mutant. Amyloid 1997;4:112-117.
33. Ando Y, Almeida MR, Ohlsson P-I, Ando E, Negi A, Suhr O, Terazaki H, Obayashi K, Ando M, Saraiva MJM. Unusual self-association properties of transthyretin Y114C related to familial amyloidotic polyneuropathy: Effects on detection and quantification. Biochem Biophys Res Commun 1999;261:264-269.
34. Quintas A, Saraiva MJM, Brito RMM. The amyloidogenic potential of transthyretin variants correlates with their tendency to aggregate in solution. FEBS Lett 1997;418:297-300.
35. Sekijima Y, Wiseman RL, Matteson J, Hammarström P, Miller SR, Sawkar AR, Balch WE, Kelly JW. The biological and chemical basis for tissue-selective amyloid disease. Cell 2005;121:73-85.
36. Blake CCF, Geisow MJ, Oatley SJ, Rerat B, Rerat C. Structure of prealbumin: secondary, tertiary and quaternary interactions determined by Fourier refinement at 1.8 A. J Mol Biol 1978;121:339-356.
37. Soprano DR, Herbert J, Soprano KJ, Schon EA, Goodman DS. Demonstration of transthyretin mRNA in the brain and other extrahepatic tissues in the rat. J Biol Chem 1985;260:11793-11798.